M. Pfeifer (Regensburg, Germany), K. Kenn (Schonau A. Konigssee, Germany)
Throat deposition of inhaled drug can explain the variability in lung deposition
L. Borgström, L. Asking, B. Olsson, L. Thorsson (Lund, Sweden; Turku, Finland)
|  |
Fracture rate in patients with asthma receiving long-term early intervention with budesonide: the START study
S. Pedersen, P. M. O‘Byrne, W. W. Busse, W. C. Tan, Y. Z. Chen, B. Lindberg, F. Radner, C. J. Lamm (Kolding, Denmark; Hamilton, Canada; Madison, United States Of America; Singapore, Singapore; Beijing, China; Lund, Sweden)
| |
Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults
S. Pedersen, O. Johnell, M. Gerhardsson de Verdier, R. Karlstrom, J. Ingelf, B. Lindberg (Kolding, Denmark; Lund, Sweden)
| |
Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
A. Van Muylem, A. Michils (Brussels, Belgium)
| |
Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma
J. Syk, K. Alving (Stockholm, Sweden)
| |
IgM seropositivity of Chlamydia pneumoniae in acute asthma attack
N. Keren, A. Hazar, D. Marasli, M. Keren, C. Önes, O. Tümer (Istanbul, Turkey)
| |
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
D. K. C. Lee, P. S. Borade, G. P. Currie, D. A. Promnitz (Ipswich, Aberdeen, United Kingdom)
| |
Relationship between asthma symptom score and attack frequency
R. Yildiz, Z. Kaya, S. Sunmez, G. Kuran, C. Cuhadaroglu, G. Okumus, E. Sengul, B. Gemicioglu, F. Erkan (Istanbul, Turkey)
| |
Value-adding using patient assessment of asthma control
C. A. Slader, H. K. Reddel, L. M. Spencer, E. G. Belousova, F. C. Thien, C. R. Jenkins, C. L. Armour, S. Z. Bosnic-Anticevich (Camperdown, Australia)
| |
The differences of medication use between women with persistent asthma receiving care from specialty and non-specialty clinics
M. Gong, S. Wang, G. Sanders, W. Bria, T. Johnson, N. M. Clark (Ann Arbor, United States Of America)
| |
Implementation of national strategy in BA treatment in Russia
V. S. Yermakov (Kaluga, Russian Federation)
| |
Effects of esomeprazole 40 mg twice-daily in adults with moderate to severe asthma who had been treated previously with inhaled steroids and long-acting β2-agonists
T. Kiljander (on behalf of the acid reflux asthma study group) (Tampere, Finland)
| |
Efficacy of esomeprazole 40 mg twice daily for 16 weeks in adults with asthma: a randomised placebo-controlled trial
T. Kiljander (on behalf of the acid reflux asthma study group) (Tampere, Finland)
| |
Airway responsiveness to capsaicin (C), but not to methacholine (M), is influenced by gastric acid secretion inhibition
M. Ferrari, L. Benini, G. Corradini, B. Cantoni, V. Lo Cascio (Verona, Italy)
| |
Basement membrane thickness (BMT) in GER-related asthma: preliminary results
C. Micheletto, S. Tognella, F. Trevisan, M. P. Visconti, R. W. Dal Negro (Bussolengo, Italy)
| |
Diagnostic value of early reversibility test
U. Gonlugur, T. E. Gonlugur, Z. Cinar, I. Akkurt (Sivas, Turkey)
| |
Exhaled nitric oxide (eNO) as a noninvasive assessment of recurrent wheezers in adults
S. Sato, J. Saito, H. Hasunuma, Y. Ishimaru, H. Kanegae, S. Kudo, M. Munakata (Fukushima, Tokyo, Japan)
| |
Churg Strauss Syndrome associated with montelukast
B. Ozlen, O. N. Hatipoglu, N. Kurtar, M. Soy, B. Eskitutuncu, L. Cevirme (Edirne, Turkey)
| |